Net income of REGENXBIO under GAAP for 2021 was $127.84 million, compared to a loss of $111.25 million in the previous year. Revenue tripled to $470.347 million from $154.567 million a year earlier.
Net income of REGENXBIO under GAAP for 2021 was $127.84 million, compared to a loss of $111.25 million in the previous year. Revenue tripled to $470.347 million from $154.567 million a year earlier. 
regenxbio.gcs-web.com
English (US) 